Septerna's Participation at the Annual Evercore Conference
Septerna, Inc. (NASDAQ: SEPN), a pioneering clinical-stage biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery, recently announced its involvement in an upcoming healthcare conference. The event is the 8th Annual Evercore Healthcare Conference, where the company's management team will engage in a fireside chat, providing insights into their latest advancements and strategies.
Event Details
The fireside chat is scheduled for December 2, 2025, at 10:25 a.m. ET. In this session, Septerna aims to highlight the breakthroughs in their drug discovery processes, showcasing the profound impact of their Native Complex Platform™. Interested parties can tune in to a live webcast of the presentation, available on their official website. This performance will also be archived for 30 days for later viewing.
Why Attend?
Attending the Evercore Healthcare Conference offers an excellent opportunity for investors, analysts, and industry enthusiasts to understand the cutting-edge developments at Septerna. The clinical pipeline features a range of novel oral small molecule drug candidates designed to meet significant medical needs, particularly in endocrinology, immunology, and metabolic diseases. Those keen on GPCR-related therapies won't want to miss this presentation.
About Septerna
Septerna, Inc. stands at the forefront of biotechnology innovation. The company is powered by a talented team of GPCR experts and drug developers who are determined to unlock new methodologies in drug discovery. Their focus is primarily on providing therapeutic solutions for patients with unmet health needs. The Native Complex Platform™ has proven crucial in pushing the boundaries of GPCR therapies, enabling more effective and innovative treatments for various diseases.
A Diverse Pipeline of Drug Candidates
At the heart of Septerna's mission is a diverse pipeline aimed at various therapeutic areas. The company is not merely focused on one aspect of medicine; rather, they are engaging in multiple programs that span endocrinology, immunology, and inflammatory responses. Their commitment to advancing healthcare continues to drive their research and development agenda.
Contact Information
For those seeking more information about Septerna or their upcoming events, please reach out to the investor relations team. Renee Leck of THRUST handles investor queries and can be contacted via email. Additionally, for media inquiries, Carly Scaduto of THRUST is available to provide insights and information.
Investor and Media Relations
For investor relations, contact Renee Leck at renee@thrustsc.com. For media inquiries, reach out to Carly Scaduto at carly@thrustsc.com.
Frequently Asked Questions
What is the purpose of Septerna's participation in the conference?
Septerna aims to share insights into their drug discovery advancements and engage with stakeholders at the Evercore Healthcare Conference.
When will the fireside chat take place?
The fireside chat is scheduled for December 2, 2025, at 10:25 a.m. ET.
How can one access the presentation?
A live webcast will be available on Septerna's website, and it will also be archived for a month for later viewing.
What is the Native Complex Platform™?
The Native Complex Platform™ is Septerna's proprietary technology designed to create innovative solutions for GPCR drug discovery.
Who should attend the event?
Investors, analysts, and anyone interested in biotech advancements will find valuable insights at the event, especially in GPCR-focused therapies.